Inici › Anèmia falciforme › Alabama › Birmingham
Assaigs clínics de Anèmia falciforme a Birmingham, AL
14 estudis de Anèmia falciforme busquen participants en centres de Birmingham i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
ReclutantFase 3
- University Of Alabama, Birmingham
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
ReclutantFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
ReclutantFase 3
- Uni of Alabama at Birmingham, Birmingham
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
ReclutantFase 1/2Voluntaris sans benvinguts
- University of Alabama Birmingham, Birmingham
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
ReclutantFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
ReclutantFase 1/2Voluntaris sans benvinguts
- University of Alabama at Birmingham, Birmingham
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
ReclutantFase 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
Early Life Exposures Among Children With Sickle Cell Disease
Reclutant
- University of Alabama at Birmingham, Birmingham
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
ReclutantFase 4
- University Of Alabama, Birmingham
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
ReclutantEstudi observacional
- Children's of Alabama (MRD-HCT), Birmingham
- Children's of Alabama (NT-DMT), Birmingham
Cognitive Remediation Intervention to Prepare for Transition of Care
ReclutantFase 2
- University of Alabama at Birmingham, Birmingham
A Long-term Follow-up Study in Patients Who Received BEAM-101
ReclutantEstudi observacional
- University of Alabama at Birmingham, Birmingham
HPC Offered for PRESERVE Expansion
ReclutantEstudi observacional
- University of Alabama, Birmingham, Birmingham
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
ReclutantEstudi observacional
- University of Alabama, Birmingham (UAB), Birmingham
Assaigs de Anèmia falciforme en altres ciutats
- Atlanta, GA22 estudis
- Washington, DC20 estudis
- Memphis, TN18 estudis
- Chicago, IL18 estudis
- Philadelphia, PA15 estudis
- New York City, NY13 estudis
- St. Louis, MO12 estudis
- Durham, NC10 estudis
- Cincinnati, OH10 estudis
- Houston, TX10 estudis
- Boston, MA10 estudis
- Pittsburgh, PA9 estudis
Altres estudis a Birmingham
- Càncer (tots els tipus)30 estudis
- Càncer de mama24 estudis
- Obesitat23 estudis
- Càncer d'ovari23 estudis
- Càncer de pulmó de cèl·lules no petites22 estudis
- Leucèmia mieloide aguda21 estudis
- Mieloma múltiple18 estudis
- EPOC17 estudis
- Malaltia cardiovascular17 estudis
- Sobrepès16 estudis
- Càncer d'endometri16 estudis
- Diabetis tipus 216 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.